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Objectives: Evaluate the functional grade of these patients and to identify the types of com-
plications found that inﬂuenced the average life span of endoprostheses the functions of
the  operated limb.
Methods: We  analyzed 14 post-operative cases of endoprosthesis, patients with malignant
bone tumors and aggressive benign bone tumors submitted to surgery between 2004 and
2014. The evaluation system used was proposed by Enneking, recommended by the Muscu-
loskeletal Tumor Society (MSTS), in addition to the radiologic evaluation.
Results: Endoprosthesis are excellent choices for the treatment of bone tumors with limb
preservation in relation to pain, strength, and patient’s emotional acceptance. Another
factor for good results is the immediate weight-bearing capacity, generating a greater inde-
pendence.
Conclusion: The authors conclude that all patients classiﬁed the therapy as excellent/good,
regardless of the type of prosthesis used, extent of injury, and/or type of tumor resection
performed.
©  2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Ortopedia
e  Traumatologia. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Avaliac¸ão  funcional  das  endopróteses  no  tratamento  de  tumores  ósseos
r  e  s  u  m  oalavras-chave: Objetivo: Avaliar o grau funcional desses pacientes e identiﬁcar os tipos de complicac¸ões
ﬂuenciaram na sobrevida das endopróteses e na func¸ão do membroeoplasias ósseas encontradas e que in
rocedimentos cirúrgicos
econstrutivos
operado.
Métodos: Foram analisados 14 pós-operatórios de endopróteses em pacientes portadores de
tumores ósseos malignos e benignos agressivos com cirurgia entre 2004 e 2014. O sistema
 Study carried out at the Pontifícia Universidade Católica de Campinas (PUC-Campinas), Hospital e Maternidade Celso Pierro, Servic¸o
e  Ortopedia e Traumatologia, Campinas, SP, Brazil.
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Prótese articular
Salvamento de membro
de avaliac¸ão foi o proposto por Enneking, preconizado pela Musculoskeletal Tumor Society
(MSTS), além da avaliac¸ão radiográﬁca.
Resultados: As endopróteses são ótimas opc¸ões no tratamento de tumores ósseos com
preservac¸ão  do membro, em relac¸ão à dor, forc¸a e aceitac¸ão emocional do paciente. Outro
fator para bons resultados é a capacidade de suporte de peso imediato, que gera uma
independência maior.
Conclusão: Todos os pacientes classiﬁcaram a terapia como excelente/boa, indiferentemente
do  tipo de prótese, extensão da lesão, tipo de tumor e ressecc¸ão feita.
© 2016 Publicado por Elsevier Editora Ltda. em nome de Sociedade Brasileira de
Ortopedia e Traumatologia. Este e´ um artigo Open Access sob uma licenc¸a CC BY-NC-NDIntroduction
With advances in protocols and treatment of cancer patients
and consequent increase in survival, the number of patients
with bone metastases has increased, as well as the inci-
dence of complications.1–4 One of the complications often
found in these patients are pathological fractures, especially in
the lower limbs, which invariably affect the meta-epiphyseal
region of the bone and requires joint reconstruction. Regarding
primary bone tumors, these have also had better outcomes
after use of multidrug therapy, resulting in limb salvage pos-
sibility; that, in most cases, is only obtained with large bony
resections, leading to the need for reconstruction of this bone
segment, which in most cases can be attained with non-
conventional endoprosthesis.
Metastatic bone disease is the most common bone
malignancy,1 primarily affecting the axial skeleton, pelvis and
femur.5,6 Metastatic involvement of the lower limbs is asso-
ciated with a greater number of pathological fractures and
promotes increased morbidity / mortality due to prolonged
bed rest, increased risk of pneumonia and thromboembolic
events.6 Under these circumstances, replacement of the bone
segment can be attained with an endoprosthesis, which
rapidly rehabilitates this patient, who  becomes an ambulatory
patient.1,7–9
Regarding primary bone tumors, osteosarcoma and Ewing’s
sarcoma, as well as giant cell tumors (GCT) of the bone, also
occur more  often in the lower limbs, with the distal femur
and proximal tibia being the preferred locations, affecting the
joint region while resulting in the need for joint replacement.
As in the upper limbs, these tumors not infrequently affect
the proximal humerus.2,7
For primary malignant and aggressive benign tumors, a
wide resection to achieve necessary safety margin results
in large bony resections and, therefore, the need for local
reconstruction.8,10
Among the techniques based on limb salvage principle,
one that has been recommended for treating bone metas-
tases in the lower limbs and the proximal humerus, due
to better response and effectiveness, is lesion resection and
replacement of the resected segment by an unconventional
endoprosthesis,5,11,12 the method of choice in our service.
For malignant primary bone tumors (osteosarcoma,
Ewing’s sarcoma, chondrosarcoma) and aggressive benign
tumors (Enneking’s B3) obtaining a broad or radical mar-
gin invariably results in large meta-epiphyseal bone loss,(http://creativecommons.org/licenses/by-nc-nd/4.0/).
requiring biological or prosthetic reconstruction.13 Large bone
resections occurring during surgical revisions of conventional
arthroplasties are another condition that requires the use of
endoprostheses.
In such cases, the biological reconstructions can be per-
formed with autologous bone graft, free or vascularized,
homologous graft (tissue bank) or other autograft meth-
ods. Although more  natural, biological reconstruction shows
severe limitations in most cases.13
Prosthetic reconstructions are performed with non-
conventional endoprostheses, which replace bones and joints.
They are of easy access, provides anatomical reconstruction of
the limb, functionally and fast, resulting in early ambulation
recovery. However, they also have a high number of compli-
cations within short- and long-term follow-up. Postoperative
complications of bone tumor resections and replacement of
the resected segment by an endoprosthesis are: infection,
aseptic implant loosening, periprosthetic fracture, implant
fracture and tumor recurrence.1,7,14
These complications can be responsible for the functional
impairment of the affected limb, implant loss and even the
amputation of the affected limb.
The purpose of this study is to identify the types of com-
plications found that inﬂuenced the average life span of the
endoprostheses and function of the operated limb of our
patients, according to the functional analysis of the MSTS.
These data can be used to improve implant manufacturing
and surgical techniques, as the improvement of orthopedic
implants and techniques used in bone defect replacement
after neoplastic resection is crucial to achieve greater dura-
bility, with fewer complications and increased functionality
of the operated limb.5,12–15
Material  and  methods
This is a retrospective study with 14 patients with malignant
and aggressive benign (Enneking’s B3) tumors, who  required
reconstructive surgery with non-conventional endoprosthe-
sis. Patients with incomplete medical records that would not
allow assessment and those who died or were transferred to
another service before completing one year of follow-up were
excluded. Patients who did not sign an Informed Consent Form
were also excluded.Mean age of patients was 56 years, with the youngest being
19 and the oldest 66 years of age. Five patients were males
and nine were females. As for the tumor site, one (7%) was
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Table 1 – Patient data.
Patient Gender Age Surgery Site Primary tumor Amputation
1 M 41 2004 Knee GCT No
2 M 52 2008 Hip Chondrosarcoma No
3 F 61 2008 Knee Chondrosarcoma Yes
4 F 66 2008 Knee Chondrosarcoma No
5 M 58 2010 Knee Chondrosarcoma Yes
6 F 81 2011 Knee Metastasis No
7 F 28 2012 Knee GCT No
8 F 60 2013 Knee Metastasis – Breast No
9 F 74 2013 Knee Chondrosarcoma Yes
10 M 65 2014 Shoulder Chondrosarcoma No
11 F 56 2014 Hip Metastasis – Kidney No
12 M 19 2014 Knee Ewing Sarcoma No
13 F 49 2014 Knee Multiple Myeloma No
14 F 31 2014 
F
p
l
i
m
m
a QQ plot of the mean scores, the assumption of normality of
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mig. 1 – Preoperative radiographies of one of the study
atients, diagnosed with GCT in the left distal femur.
ocated in the shoulder, two (14%) in the hip and 11 (78%)
n the knee (Fig. 1). Considering tumor type, one (7%) was a
yeloma, one (7%) an Ewing’s tumor, three (21%) were bone
etastases and six (42%) were chondrosarcomas. All surgeries
ig. 2 – Intraoperative and postoperative radiographic images of 
odular endoprosthesis of the distal femur with articulated kneKnee GCT No
were performed between 2004 and 2014 (Fig. 2). Three patients
underwent amputation due to late complications of the
endoprosthesis primary procedure. These data are shown in
Table 1.
Functional assessment was performed according to the
classiﬁcation recommended by Enneking, adopted by  the
Musculoskeletal Tumor Society (MSTS), whose parameters
are mobility, pain, function, emotional acceptance, supports,
walking, gait, range of motion (ROM) and strength. Each func-
tional assessment parameter was evaluated with six scoring
levels, with the highest score being ﬁve and the lowest, zero.
Radiographic imaging was also evaluated regarding the endo-
prosthesis stability, as shown in Table 2.
Using the R and Excel software programs, the exploratory
data analysis was carried out with 11 patients (three were
excluded from the data analysis due to amputation) submit-
ted to endoprosthesis treatment. This work aims to evaluate
whether the endoprosthesis is an effective treatment. Usingscores was conﬁrmed, that is, as the points are close to the
line, the t-test can be used to compare the means of the data,
as shown in Table 3 and Fig. 3.
the same patient, who was submitted to unconventional
e.
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Table 2 – Questionnaire results.
Patient Pain Function Emotional acceptance Supports Walking Gait Strength ROM
1 3 5 4 6 5 4 6 2
2 6 5 6 2 4 3 6 5
3 – – – – – – – –
4 4 4 6 1 3 2 4 6
5 – – – – – – – –
6 6 2 6 2 3 2 6 3
7 6 5 4 6 6 4 6 5
8 6 2 6 1 2 2 6 6
9 – – – – – – – –
10 4 1 4 6 – – 0 0
11 4 3 5 1 3 2 6 4
12 5 5 4 6 5 5 6 4
13 4 3 2 
14 3 3 6 
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Fig. 3 – Q–Q plot of the mean total scores.
Results
The score value for each patient may vary from eight to 48
and the mean value obtained was 32. Half of the patients who
answered the questionnaire had a score between 30 and 36.
The lowest observed score was 15 and the highest was 42.
In the overall analysis of the endoprosthesis effectiveness
and after establishing that mean scores higher than three is
considered a good result and using Student’s t-test (compari-
son of means) to determine the mean scores, a p value = 0.002
was obtained, a statistically signiﬁcant result.
All variables were also analyzed separately, using the same
Student’s t method, considering a response higher than three
a satisfactory result. The results ranged from 0.005 p to 0.8.
Pain, emotional acceptance and strength were statistically
Table 3 – Mean of total scores of questions per patient.
Patient Mean of scores
1 4.375
2 4.625
4 3.75
6 3.75
7 5.25
8 3.875
10 1.875
11 3.5
12 5
13 3.75
14 4.253 4 3 6 5
6 6 2 6 2
signiﬁcant and showed a p value <0.05. As for function, sup-
ports, walking, gait and ROM, they all showed a p value >0.05.
Regarding radiographies, all prostheses were stable, with
no apparent signs of loosening or infection, except for the
patients who underwent amputation due to postoperative
complications or tumor recurrence. All radiographies were
performed in the same service.
Discussion
The current literature is scarce regarding functional results
after limb salvage surgery in patients with malignant and
aggressive benign tumors, most likely due to the rarity of
primary bone tumors. In recent decades, treatment of bone
tumors went through changes, since the previously pre-
ferred treatment for most cases was amputation. In the
beginning of this century, limb salvage surgery became pre-
dominant among surgeons, and amputations become only an
option, or the treatment of complications after limb salvage
surgeries.15,16
In a study carried out at Centro Infantil Boldrini published
in 2008, authors compared two groups of patients with bone
sarcomas in the distal end of the femur, one with total and
another with partial endoprostheses, there was no inﬂuence
on the overall functional outcome and a statistically signiﬁ-
cant difference was observed only regarding stability.17
In general, non-conventional endoprostheses are excel-
lent devices in the reconstruction of large bone resections;
however, they have mechanical limitations, which must be
considered before their indication.
This study agrees with the current literature and obtained
the same results, showing that the endoprosthesis is an excel-
lent option in the treatment of bone tumors with limb salvage,
especially in relation to pain, strength and patient emotional
acceptance, according to the results shown in Table 4. During
the interview, all patients emphasized emotional improve-
ment after surgery, mainly due to pain improvement. Another
factor that contributes to the good results demonstrated in
this study is the immediate load-bearing capacity, which
results in greater patient independence.
However, it is known that the range of motion (ROM) shows
limitation in relationship to the contralateral limb, mainly
due to loss of muscle mass, either because of age, non-use or
r e v b r a s o r t o p . 2 0 1 6
Table 4 – Results of tests, their efﬁcacy and respective
p-value.
Results of the mean comparison test
Variable Effective p-Value
Pain Yes 0.001
Function No 0.150
Emotional acceptance Yes 0.005
Supports No 0.200
Walking No 0.100
Gait No 0.800
Strength Yes 0.001
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1ROM No 0.090
Total Yes 0.002
esection during surgery. This loss of muscle mass also wors-
ns ambulation capacity and increases the need for assistance
uring gait. As a consequence of limb deterioration, limb func-
ion becomes limited, which again demonstrates the results
hown in this study.
onclusion
ll patients classiﬁed the therapy as excellent/good, regard-
ess of the prosthesis type, lesion extension, tumor type and
esection performed.
Most patients with bone tumors with limb salvage indi-
ation had a life prognosis below that found in the general
opulation, so the early return to everyday activities, inde-
endence and ambulation capacity are the treatment goals,
aking endoprosthesis a viable and effective option for these
atients.
Despite the limited study sample, the results obtained from
he questionnaire support the current literature. Given the
imitation of patients that are adequate for this sample and
he fact that it is a current issue, we  believe that the endo-
rosthesis is currently an excellent choice.
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